Skip to content
zameds

Potassium chloride, sodium chloride, sodium lactate

Sold as Sabax darrows, Darrow's, Sabax plasmalyte l, Modified ringer-lactate fresenius

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
3
Registrations
4

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Adcock Ingram Critical Care (Pty) LtdSabax darrows, Sabax plasmalyte lNot stated280532, K0225Not determinedNone
Bodene (Pty) Ltd Trading As IntramedCancelledDarrow'ssolutionE0117Not determinedNone
Fresenius Kabi Manufacturing SA (Pty) LtdModified ringer-lactate freseniussolutionL0340Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Sabax darrows

EACH 1 000 ml SOLUTION CONTAINS POTASSIUM CHLORIDE 2,6 g SODIUM CHLORIDE 4 g SODIUM LACTATE 5,9 g

Not listed28053228/24/0532RegisteredNot determinedNone
Darrow's solution

EACH 200 ml SOLUTION CONTAINS POTASSIUM CHLORIDE 0,52 g SODIUM CHLORIDE 0,8 g SODIUM LACTATE 1,18 g

SolutionE0117E/24/117CancelledNot determinedNone
Sabax plasmalyte l

EACH 100 ml CONTAINS :POTASSIUM CHLORIDE 40 mg, SODIUM CHLORIDE 600 mg, SODIUM LACTATE 320 mg

Not listedK0225K/24/225RegisteredNot determinedNone
Modified ringer-lactate solution fresenius

EACH 1000 ml CONTAINS POTASSIUM CHLORIDE 400 mg SODIUM CHLORIDE 6 g SODIUM LACTATE 3,25 g

SolutionL0340L/24/340RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S3: Potassium

    • when intended for intravenous infusion or for injection;
    • except when contained in oral rehydration preparations; (S0)
    • except in oral preparations or mixtures containing more than 20 millimoles (1500mg) of potassium per 24 hours. (S2)

    Consolidated Schedules 06 July 2026, lines 4148 to 4153

  • S2: Potassium

    • in oral preparations or mixtures containing more than 20 millimoles (1500mg) of potassium per 24 hours;
    • except when intended for intravenous infusion or for injection; (S3) and
    • except when contained in oral rehydration preparations. (S0)

    Consolidated Schedules 06 July 2026, lines 2563 to 2569

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles